10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
MERCK & CO., INC. | |||
Ticker: MRK Fiscal Year: 2014 | |||
Consolidated Statement of Income | |||
Period Ending Dec 31, 2014 10-K (Filed: Feb 27, 2015) | |||
(In Millions, except shares in actual) | |||
12 Months Ended | 12 Months Ended | 12 Months Ended | |
Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | |
Sales | $ 42,237 | 44,033 | 47,267 |
Costs, Expenses and Other | |||
Materials and production | 16,768 | 16,954 | 16,446 |
Marketing and administrative | 11,606 | 11,911 | 12,776 |
Research and development | 7,180 | 7,503 | 8,168 |
Restructuring costs | 1,013 | 1,709 | 664 |
Equity income from affiliates | (257) | (404) | (642) |
Other (income) expense, net | (11,356) | 815 | 1,116 |
Total Costs, Expenses and Other | 24,954 | 38,488 | 38,528 |
Income Before Taxes | 17,283 | 5,545 | 8,739 |
Taxes on Income | 5,349 | 1,028 | 2,440 |
Net Income | 11,934 | 4,517 | 6,299 |
Less: Net Income Attributable to Noncontrolling Interests | 14 | 113 | 131 |
Net Income Attributable to Merck & Co., Inc. | 11,920 | 4,404 | 6,168 |
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) | 4.12 | 1.49 | 2.03 |
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) | 4.07 | 1.47 | 2.00 |
External Links | |
MERCK & CO., INC. (MRK) Fiscal Year 2014 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |